NL300195I2 - Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC. - Google Patents

Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC.

Info

Publication number: NL300195I2
Authority: NL; Netherlands
Prior art keywords: ftc; zidovudine; synergistic combinations; synergistic; combinations
Prior art date: 1995-03-30

Application number

NL300195C

Other languages

English (en)

Other versions

NL300195I1 (nl

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-30

Filing date

2005-05-09

Publication date

2005-11-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300195(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-03-30 Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en

1995-03-30 Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en

2005-05-09 Application filed by Wellcome Found filed Critical Wellcome Found

2005-08-01 Publication of NL300195I1 publication Critical patent/NL300195I1/nl

2005-11-01 Publication of NL300195I2 publication Critical patent/NL300195I2/nl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Virology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicinal Preparation (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Cephalosporin Compounds (AREA)

NL300195C 1995-03-30 2005-05-09 Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC. NL300195I2 (nl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9506490.3A GB9506490D0 (en)	1995-03-30	1995-03-30	Antiviral combinations
GBGB9506489.5A GB9506489D0 (en)	1995-03-30	1995-03-30	Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en)	1995-03-30	1996-03-28	Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc

Publications (2)

Publication Number	Publication Date
NL300195I1 NL300195I1 (nl)	2005-08-01
NL300195I2 true NL300195I2 (nl)	2005-11-01

Family

ID=26306774

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL300195C NL300195I2 (nl)	1995-03-30	2005-05-09	Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC.

Country Status (36)

Country	Link
US (1)	US6417191B1 (nl)
EP (1)	EP0817637B1 (nl)
JP (1)	JP2954357B2 (nl)
KR (1)	KR100542536B1 (nl)
CN (1)	CN1103593C (nl)
AP (1)	AP652A (nl)
AT (1)	ATE220551T1 (nl)
AU (1)	AU715213B2 (nl)
BR (3)	BRPI9607851B8 (nl)
CA (1)	CA2216634C (nl)
CZ (1)	CZ295940B6 (nl)
DE (3)	DE122005000029I1 (nl)
DK (1)	DK0817637T3 (nl)
EA (1)	EA000626B3 (nl)
EE (1)	EE04047B1 (nl)
ES (1)	ES2179193T3 (nl)
FR (1)	FR05C0022I2 (nl)
GE (1)	GEP20022647B (nl)
HK (1)	HK1009401A1 (nl)
HU (1)	HU224010B1 (nl)
IL (1)	IL117727A (nl)
LU (1)	LU91171I2 (nl)
MX (1)	MX9707316A (nl)
MY (1)	MY115461A (nl)
NL (1)	NL300195I2 (nl)
NO (2)	NO313787B1 (nl)
NZ (1)	NZ306419A (nl)
OA (1)	OA10616A (nl)
PL (1)	PL187085B1 (nl)
PT (1)	PT817637E (nl)
RO (1)	RO117995B1 (nl)
SI (1)	SI0817637T1 (nl)
SK (1)	SK283825B6 (nl)
TR (1)	TR199701074T1 (nl)
UA (1)	UA60293C2 (nl)
WO (1)	WO1996030025A1 (nl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0938321B1 (en) *	1996-06-25	2004-01-14	Glaxo Group Limited	Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv
US6113920A (en) *	1996-10-31	2000-09-05	Glaxo Wellcome Inc.	Pharmaceutical compositions
TW536403B (en) *	1997-03-24	2003-06-11	Glaxo Group Ltd	An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
GB9709945D0 (en) *	1997-05-17	1997-07-09	Glaxo Group Ltd	A novel salt
EP0979082A1 (en) *	1997-05-17	2000-02-16	Glaxo Group Limited	Antiviral combinations containing the carbocyclic nucleoside 1592u89
AU769660B2 (en) *	1997-05-17	2004-01-29	Glaxo Group Limited	Carbocyclic nucleoside hemisulfate and its use in treating viral infections
GB9809213D0 (en) *	1998-04-29	1998-07-01	Glaxo Group Ltd	Pharmaceutical compositions
WO1999060988A2 (en) *	1998-05-29	1999-12-02	University Of Florida	Combination therapy for treatment of fiv infection
US6875773B1 (en)	1998-05-29	2005-04-05	Ben M. Dunn	Combination therapy for treatment of FIV infection
GB9820417D0 (en) *	1998-09-18	1998-11-11	Glaxo Group Ltd	Antiviral combinations
US6432966B2 (en)	1999-10-29	2002-08-13	Smithkline Beecham Corporation	Antiviral combinations
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) *	2001-05-11	2011-03-24	Cipla Medpro Pty Ltd	Pharmaceutical composition.
AR040242A1 (es) *	2002-06-04	2005-03-23	Glaxo Group Ltd	Composiciones farmaceuticas
EP3025718A1 (en)	2003-01-14	2016-06-01	Gilead Sciences, Inc.	Compositions and methods for combination antiviral therapy
MXPA05010081A (es)	2003-03-24	2005-11-23	Hoffmann La Roche	Bencil-piridazinonas como inhibidores de transcriptasa inversa.
WO2005040816A1 (en)	2003-10-24	2005-05-06	Immunaid Pty Ltd	Method of therapy
TWI471145B (zh)	2005-06-13	2015-02-01	Bristol Myers Squibb & Gilead Sciences Llc	單一式藥學劑量型
KR20080056220A (ko)	2005-10-19	2008-06-20	에프. 호프만-라 로슈 아게	페닐-아세트아마이드 ｎｎｒｔ 저해제
CA2671478C (en)	2006-12-13	2015-02-17	F. Hoffmann-La Roche Ag	Non-nucleoside reverse transcriptase inhibitors
US9095519B2 (en) *	2007-02-09	2015-08-04	Alphapharm Pty Ltd	Dosage form containing two or more active pharmaceutical ingredients in different physical forms
CA2763373C (en)	2009-05-27	2018-01-09	Immunaid Pty Ltd	Methods and systems for determining preferred times for administering therapy to treat diseases
RS57728B1 (sr)	2010-01-27	2018-12-31	Viiv Healthcare Co	Antivirusna terapija
CA2918707A1 (en)	2013-08-29	2015-03-05	Teva Pharmaceuticals Industries Ltd.	Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
CA2942877A1 (en)	2014-04-08	2015-10-15	Nitzan SHAHAR	Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
CN112430250A (zh)	2014-08-12	2021-03-02	莫纳什大学	定向淋巴的前药
CN108137482B (zh)	2015-09-08	2024-03-15	莫纳什大学	定向淋巴的前药
EP4306524A3 (en) *	2017-08-29	2024-09-11	PureTech LYT, Inc.	Lymphatic system-directing lipid prodrugs
US11883497B2 (en)	2017-08-29	2024-01-30	Puretech Lyt, Inc.	Lymphatic system-directing lipid prodrugs
US11608345B1 (en)	2017-12-19	2023-03-21	Puretech Lyt, Inc.	Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en)	2017-12-19	2022-04-19	Puretech Lyt, Inc.	Lipid prodrugs of mycophenolic acid and uses thereof
WO2021159021A1 (en)	2020-02-05	2021-08-12	Puretech Lyt, Inc.	Lipid prodrugs of neurosteroids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4724232A (en) *	1985-03-16	1988-02-09	Burroughs Wellcome Co.	Treatment of human viral infections
US5047407A (en)	1989-02-08	1991-09-10	Iaf Biochem International, Inc.	2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en)	1988-06-10	1992-06-16	Regents Of The University Of Minnesota	Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) *	1988-06-27	1988-08-03	Wellcome Found	Therapeutic nucleosides
US5204466A (en)	1990-02-01	1993-04-20	Emory University	Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) *	1990-05-02	1990-06-27	Glaxo Group Ltd	Chemical compounds
GB9104740D0 (en)	1991-03-06	1991-04-17	Wellcome Found	Antiviral nucleoside combination
SK279262B6 (sk) *	1991-05-16	1998-08-05	Glaxo Group Limited	Protivírusová zmes, farmaceutický prostriedok s je
ES2138624T3 (es) *	1992-05-13	2000-01-16	Wellcome Found	Combinaciones terapeuticas.
US5723490A (en)	1992-09-08	1998-03-03	Vertex Pharmaceuticals Incorporated	THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en)	1994-08-26	1994-10-19	Wellcome Found	A novel salt
US5869461A (en)	1995-03-16	1999-02-09	Yale University	Reducing toxicity of L-nucleosides with D-nucleosides
CN1306430A (zh)	1996-06-25	2001-08-01	葛兰素集团有限公司	用于治疗hiv感染的含有vx478、叠氮胸苷和/或1592u89的复方制剂
EP0938321B1 (en)	1996-06-25	2004-01-14	Glaxo Group Limited	Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv
DE10226522A1 (de) *	2002-06-14	2003-12-24	Degussa	Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

1996
- 1996-03-27 MY MYPI96001152A patent/MY115461A/en unknown
- 1996-03-28 HU HU9801571A patent/HU224010B1/hu active Protection Beyond IP Right Term
- 1996-03-28 KR KR1019970706824A patent/KR100542536B1/ko not_active IP Right Cessation
- 1996-03-28 CN CN96194050A patent/CN1103593C/zh not_active Expired - Lifetime
- 1996-03-28 PL PL96322532A patent/PL187085B1/pl unknown
- 1996-03-28 RO RO97-01795A patent/RO117995B1/ro unknown
- 1996-03-28 BR BRPI9607851A patent/BRPI9607851B8/pt unknown
- 1996-03-28 US US08/930,225 patent/US6417191B1/en not_active Expired - Lifetime
- 1996-03-28 TR TR97/01074T patent/TR199701074T1/xx unknown
- 1996-03-28 EA EA199700203A patent/EA000626B3/ru not_active IP Right Cessation
- 1996-03-28 DE DE200512000029 patent/DE122005000029I1/de active Pending
- 1996-03-28 MX MX9707316A patent/MX9707316A/es active IP Right Grant
- 1996-03-28 DK DK96911953T patent/DK0817637T3/da active
- 1996-03-28 DE DE1996622386 patent/DE122005000029I2/de active Active
- 1996-03-28 NZ NZ306419A patent/NZ306419A/xx not_active IP Right Cessation
- 1996-03-28 CZ CZ19973090A patent/CZ295940B6/cs not_active IP Right Cessation
- 1996-03-28 BR BRPI9607851-0A patent/BR9607851B1/pt active IP Right Grant
- 1996-03-28 AP APAP/P/1997/001089A patent/AP652A/en active
- 1996-03-28 AT AT96911953T patent/ATE220551T1/de active
- 1996-03-28 ES ES96911953T patent/ES2179193T3/es not_active Expired - Lifetime
- 1996-03-28 PT PT96911953T patent/PT817637E/pt unknown
- 1996-03-28 EE EE9700240A patent/EE04047B1/xx not_active IP Right Cessation
- 1996-03-28 AU AU54972/96A patent/AU715213B2/en not_active Expired
- 1996-03-28 GE GEAP19963898A patent/GEP20022647B/en unknown
- 1996-03-28 EP EP96911953A patent/EP0817637B1/en not_active Expired - Lifetime
- 1996-03-28 DE DE69622386T patent/DE69622386T2/de not_active Expired - Lifetime
- 1996-03-28 WO PCT/EP1996/001352 patent/WO1996030025A1/en active IP Right Grant
- 1996-03-28 BR BRPI9612992-1A patent/BRPI9612992B1/pt not_active IP Right Cessation
- 1996-03-28 SI SI9630494T patent/SI0817637T1/xx unknown
- 1996-03-28 CA CA002216634A patent/CA2216634C/en not_active Expired - Lifetime
- 1996-03-28 UA UA97094740A patent/UA60293C2/uk unknown
- 1996-03-28 JP JP8528931A patent/JP2954357B2/ja not_active Expired - Lifetime
- 1996-03-28 SK SK1295-97A patent/SK283825B6/sk not_active IP Right Cessation
- 1996-03-29 IL IL11772796A patent/IL117727A/xx not_active IP Right Cessation
1997
- 1997-09-17 OA OA70075A patent/OA10616A/en unknown
- 1997-09-29 NO NO19974510A patent/NO313787B1/no not_active IP Right Cessation
1998
- 1998-09-04 HK HK98110458A patent/HK1009401A1/xx not_active IP Right Cessation
2005
- 2005-05-04 LU LU91171C patent/LU91171I2/fr unknown
- 2005-05-09 NL NL300195C patent/NL300195I2/nl unknown
- 2005-05-09 FR FR05C0022C patent/FR05C0022I2/fr active Active
- 2005-05-24 NO NO2005014C patent/NO2005014I2/no unknown

Also Published As

Publication number	Publication date
HU224010B1 (hu)	2005-04-28
HUP9801571A3 (en)	2001-04-28
DE122005000029I1 (de)	2005-10-06
CA2216634A1 (en)	1996-10-03
PL187085B1 (pl)	2004-05-31
NO2005014I2 (no)	2008-02-11
DE69622386T2 (de)	2003-02-13
IL117727A (en)	1999-11-30
NO974510L (no)	1997-09-29
MX9707316A (es)	1997-11-29
HK1009401A1 (en)	1999-09-10
NO2005014I1 (no)	2005-06-06
EA000626B3 (ru)	2016-04-29
EP0817637B1 (en)	2002-07-17
IL117727A0 (en)	1996-07-23
AP652A (en)	1998-06-19
KR19980703420A (ko)	1998-11-05
BR9607851B1 (pt)	2009-01-13
DE122005000029I2 (de)	2006-04-27
MY115461A (en)	2003-06-30
GEP20022647B (en)	2002-03-25
OA10616A (en)	2001-03-15
FR05C0022I2 (nl)	2005-10-21
PL322532A1 (en)	1998-02-02
RO117995B1 (ro)	2002-12-30
FR05C0022I1 (nl)	2005-06-10
BRPI9612992B1 (pt)	2020-08-04
CA2216634C (en)	2004-07-20
ES2179193T3 (es)	2003-01-16
ATE220551T1 (de)	2002-08-15
CZ295940B6 (cs)	2005-12-14
CN1103593C (zh)	2003-03-26
CN1185110A (zh)	1998-06-17
AU715213B2 (en)	2000-01-20
JP2954357B2 (ja)	1999-09-27
SI0817637T1 (en)	2002-10-31
DE69622386D1 (de)	2002-08-22
HUP9801571A2 (hu)	1999-01-28
NO313787B1 (no)	2002-12-02
EE9700240A (et)	1998-04-15
EA199700203A1 (ru)	1998-02-26
NO974510D0 (no)	1997-09-29
US6417191B1 (en)	2002-07-09
SK283825B6 (sk)	2004-02-03
WO1996030025A1 (en)	1996-10-03
BR9607851A (pt)	1998-07-21
EA000626B1 (ru)	1999-12-29
SK129597A3 (en)	1998-07-08
CZ309097A3 (cs)	1998-05-13
AU5497296A (en)	1996-10-16
EP0817637A1 (en)	1998-01-14
EE04047B1 (et)	2003-06-16
KR100542536B1 (ko)	2006-03-23
DK0817637T3 (da)	2002-11-11
LU91171I9 (nl)	2018-12-28
BRPI9607851B8 (pt)	2019-11-05
JPH10511682A (ja)	1998-11-10
LU91171I2 (fr)	2005-07-04
AP9701089A0 (en)	1997-10-31
NZ306419A (en)	2000-01-28
PT817637E (pt)	2002-11-29
NL300195I1 (nl)	2005-08-01
TR199701074T1 (xx)	1998-02-21
UA60293C2 (uk)	2003-10-15

Publication	Publication Date	Title
NL300195I2 (nl)	2005-11-01	Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC.
TR199600697A2 (tr)	1997-03-21	Tasit gövdesi yapisi.
BR9701946B1 (pt)	2010-11-03	composição condicionadora da pele.
AU3262797A (en)	1998-01-14	Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
TR199600371A2 (tr)	1996-12-21	Organosilan bilesiklerinin harmanlari ve bunlarin kullanimi.
BR9701947B1 (pt)	2009-05-05	composição condicionadora da pele.
DE69634489D1 (de)	2005-04-21	Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
IT9022341A0 (it)	1990-12-11	Estratti da tessuti animali, utili in terapia e in diagnostica.
IT1302023B1 (it)	2000-07-20	Composizione cosmetica deodorante e/o idratante.
DE59812250D1 (de)	2004-12-16	Gehstütze, stock oder dgl.
BR9401367A (pt)	1994-10-18	Composição contendo hidrolisado de cereal, composição de carne contendo imitador de gordura, e composição de carne fragmentada.
HU9903098D0 (en)	1999-10-28	Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
NL1000279C2 (nl)	1996-11-05	Met hitte behandelde polysacharidecrème.
NL1000591C2 (nl)	1996-12-20	Weefsel.
NO307542B1 (no)	2000-04-25	Kasseformet legeme, særlig postkasse, samt front til samme
TR199600041A2 (tr)	1996-08-21	Cilt temizleme bilesimi.
ITRM950305A0 (it)	1995-05-11	Composizione cosmetica ad azione dermoprotettiva e dermonutritiva.
IT242888Y1 (it)	2002-02-04	Orecchino con chiusura regolabile.
BR7601412U (pt)	1998-07-21	Aparelho aplicável no tratamento de fluxo de graos em geral
ITRM950514A0 (it)	1995-07-27	Schiaccianoci imperio.
RU95117476A (ru)	1997-10-27	Природный дубитель кожи
ES1031649Y (es)	1996-06-01	Pinza para exprimir infusiones.
ES1032202Y (es)	1996-09-01	Planeador cometa.
FI955877A0 (fi)	1995-12-07	I staellet foer en oljebytespropp monterbar vaermare foer smoerjolja
IT1288138B1 (it)	1998-09-10	Dispositivo per la costruzione di semigusci rivestiti, in particolare per custodie di occhiali, o similli.